Ruxoprubart is set to be developed as a novel treatment for several ... (aHUS), C3 Glomerulopathy (C3G), IgA Nephropathy (IgAN), ANCA-Associated Vasculitis (AAV), and Dermatomyositis (DM).

In recent years, Dr. Manel Mejbri has actively contributed to several collaborative international research studies in the ...

We present two cases where adult patients with IgA vasculitis (IgAV) nephritis were successfully treated with Telitacicept, experienced no adverse reactions during the follow-up. Therefore, ...

Fabhalta also recently showed encouraging top-line results in IgA nephropathy (IgAN), which ... and already approved for ANCA-associated vasculitis. Apellis’s injectable C3 inhibitor Empaveli ...

After the histopathological diagnosis of IgA vasculitis following the first SBE, PSL (60 mg/kg) therapy was initiated. Ganciclovir (5 mg/kg two times per day) was added to the PSL treatment according ...

thyroid treatment), some people have jaundiced (yellow) skin. They also may experience itching and a rash called Henoch-Schonlein Purpura, also known as IgA vasculitis. Hypothyroidism, on the other ...

Maintenance therapy for ANCA vasculitis (MMF - 2g/day at complete ... nephrotic syndrome as steroid sparing agent. In IgA nephropathy as steroid-sparing agent in Chinese population (6). Treatment with ...

Despite the escalation in treatment ... his orbital inflammatory disease and vasculitis screens both returned negative results (creatine kinase 31 U/L (NR 30–170 U/L), serum IgG 12.1 g/L (NR 5.8–13.7 ...